Elevated levels of mitophagy inhibitor LRPPRC are positively correlated with poor prognosis and shorter survival in PC patients, suggesting an anti-cancer effect of mitophagy (Zou et al., 2014). The gene discussed is LRPPRC; the disease is cancer.